193 related articles for article (PubMed ID: 20710013)
21. Progressive multifocal leukoencephalopathy: why gray and white matter.
Gheuens S; Wüthrich C; Koralnik IJ
Annu Rev Pathol; 2013 Jan; 8():189-215. PubMed ID: 23092189
[TBL] [Abstract][Full Text] [Related]
22. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases.
Boren EJ; Cheema GS; Naguwa SM; Ansari AA; Gershwin ME
J Autoimmun; 2008; 30(1-2):90-8. PubMed ID: 18191544
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic and Prognostic Value of JC Virus DNA in Plasma in Progressive Multifocal Leukoencephalopathy.
Ferretti F; Bestetti A; Yiannoutsos CT; Musick BS; Gerevini S; Passeri L; Bossolasco S; Boschini A; Franciotta D; Lazzarin A; Cinque P
Clin Infect Dis; 2018 Jun; 67(1):65-72. PubMed ID: 29346632
[TBL] [Abstract][Full Text] [Related]
24. Immunology of progressive multifocal leukoencephalopathy.
Jelcic I; Jelcic I; Faigle W; Sospedra M; Martin R
J Neurovirol; 2015 Dec; 21(6):614-22. PubMed ID: 25740538
[TBL] [Abstract][Full Text] [Related]
25. Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.
Felli V; Di Sibio A; Anselmi M; Gennarelli A; Sucapane P; Splendiani A; Catalucci A; Marini C; Gallucci M
Neuroradiol J; 2014 Dec; 27(6):657-64. PubMed ID: 25489887
[TBL] [Abstract][Full Text] [Related]
26. Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome.
Gheuens S; Bord E; Kesari S; Simpson DM; Gandhi RT; Clifford DB; Berger JR; Ngo L; Koralnik IJ
J Virol; 2011 Jul; 85(14):7256-63. PubMed ID: 21543472
[TBL] [Abstract][Full Text] [Related]
27. Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry.
Prosperini L; de Rossi N; Scarpazza C; Moiola L; Cosottini M; Gerevini S; Capra R;
PLoS One; 2016; 11(12):e0168376. PubMed ID: 27997580
[TBL] [Abstract][Full Text] [Related]
28. Progressive multifocal leukoencephalopathy: new concepts.
Lima MA
Arq Neuropsiquiatr; 2013 Sep; 71(9B):699-702. PubMed ID: 24141508
[TBL] [Abstract][Full Text] [Related]
29. Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy.
Tan CS; Bord E; Broge TA; Glotzbecker B; Mills H; Gheuens S; Rosenblatt J; Avigan D; Koralnik IJ
J Acquir Immune Defic Syndr; 2012 Jul; 60(3):244-8. PubMed ID: 22549384
[TBL] [Abstract][Full Text] [Related]
30. Development of demyelinating lesions in progressive multifocal leukoencephalopathy (PML): Comparison of magnetic resonance images and neuropathology of post-mortem brain.
Ono D; Shishido-Hara Y; Mizutani S; Mori Y; Ichinose K; Watanabe M; Tanizawa T; Yokota T; Uchihara T; Fujigasaki H
Neuropathology; 2019 Aug; 39(4):294-306. PubMed ID: 31155757
[TBL] [Abstract][Full Text] [Related]
31. [Progressive multifocal leukoencephalopathy--epidemiology, clinical pictures, diagnosis and therapy].
Kishida S
No To Shinkei; 2007 Feb; 59(2):125-37. PubMed ID: 17315754
[TBL] [Abstract][Full Text] [Related]
32. [Progressive multifocal leukoencephalopathy--epidemiology, clinical pictures, diagnosis and therapy].
Kishida S
Brain Nerve; 2007 Feb; 59(2):125-37. PubMed ID: 17380777
[TBL] [Abstract][Full Text] [Related]
33. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.
Koralnik IJ; Du Pasquier RA; Kuroda MJ; Schmitz JE; Dang X; Zheng Y; Lifton M; Letvin NL
J Immunol; 2002 Jan; 168(1):499-504. PubMed ID: 11751998
[TBL] [Abstract][Full Text] [Related]
34. PCR detection of JC virus DNA in brain tissue from patients with and without progressive multifocal leukoencephalopathy.
Ferrante P; Caldarelli-Stefano R; Omodeo-Zorini E; Vago L; Boldorini R; Costanzi G
J Med Virol; 1995 Nov; 47(3):219-25. PubMed ID: 8551272
[TBL] [Abstract][Full Text] [Related]
35. Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis.
Marzocchetti A; Sanguinetti M; Giambenedetto SD; Cingolani A; Fadda G; Cauda R; De Luca A
J Neurovirol; 2007 Aug; 13(4):338-46. PubMed ID: 17849317
[TBL] [Abstract][Full Text] [Related]
36. AIDS-related progressive multifocal leukoencephalopathy in the era of HAART: report of two cases and review of the literature.
Wyen C; Lehmann C; Fätkenheuer G; Hoffmann C
AIDS Patient Care STDS; 2005 Aug; 19(8):486-94. PubMed ID: 16124842
[TBL] [Abstract][Full Text] [Related]
37. Slowly progressive fatal PML-IRIS following antiretroviral initiation at CD4+ nadir of 350 cells/mm
Sandhu MR; Rutledge R; Grant M; Mahajan A; Spudich S
Int J STD AIDS; 2019 Jul; 30(8):810-813. PubMed ID: 31046614
[No Abstract] [Full Text] [Related]
38. A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
Lee P; Plavina T; Castro A; Berman M; Jaiswal D; Rivas S; Schlain B; Subramanyam M
J Clin Virol; 2013 Jun; 57(2):141-6. PubMed ID: 23465394
[TBL] [Abstract][Full Text] [Related]
39. Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression.
Gheuens S; Pierone G; Peeters P; Koralnik IJ
J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):247-54. PubMed ID: 19828476
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility-Weighted MR Imaging Hypointense Rim in Progressive Multifocal Leukoencephalopathy: The End Point of Neuroinflammation and a Potential Outcome Predictor.
Thurnher MM; Boban J; Rieger A; Gelpi E
AJNR Am J Neuroradiol; 2019 Jun; 40(6):994-1000. PubMed ID: 31122919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
